Hormone therapy no aid for cardiovascular disease prevention, and calcium/vitamin D supplementation no aid for universal fracture prevention
SGLT2 Inhibitors Improve Outcomes in Patients With Diabetes Plus Kidney Disease
Benefits include lower risk for dialysis, hospitalization for myocardial infarction, heart failure, acute kidney injury, and diabetic ketoacidosis